|
|
|
| home > white papers > Outsourcing and Insourcing: How Eurofins solves the bio/pharma industry’s challenges associated with meeting drug development timelines and budgets with restricted headcounts - Eurofins BioPharma Product Testing |
|
|
 WHITE PAPERS |
|
Eurofins BioPharma Product Testing
|
|
Outsourcing and Insourcing: How Eurofins solves the bio/pharma industry’s challenges associated with meeting drug development timelines and budgets with restricted headcounts
|
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
‘Privates Leading the Disruption in Healthcare’ Conference
NEW YORK, NY – APRIL 7, 2022 – David MacMurchy, CEO and Robert Jones,
Chief Financial Officer, Lightship, are providing key insights into how
precision medicine is changing the landscape of clinical trial
development at Goldman Sach’s invitation only event “The New Guard:
Privates Leading the Disruption in Healthcare” on April 7th. Lightship
is a global virtual-first and hybrid clinical research services
provider.
More info >> |
|
 |
White Papers |
 |
|
Technology Solutions - Driving efficiencies, quality and operational excellence
Worldwide Clinical Trials Ltd
Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >> |
|
|
|
